Search

everythinglearnresearchcommunity

for

Search:↓

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Dr. Jorizzo questions the long-term benefits of minoxidil and tretinoin, while Dr. Olsen defends their effectiveness and stresses the need for public education on these treatments.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.